↓ Skip to main content

Prostate Cancer Stem Cells and Nanotechnology: A Focus on Wnt Signaling

Overview of attention for article published in Frontiers in Pharmacology, March 2017
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
8 X users

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
68 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Prostate Cancer Stem Cells and Nanotechnology: A Focus on Wnt Signaling
Published in
Frontiers in Pharmacology, March 2017
DOI 10.3389/fphar.2017.00153
Pubmed ID
Authors

Wei Qin, Yongjiang Zheng, Bin-Zhi Qian, Meng Zhao

Abstract

Prostate cancer is the most common cancer among men worldwide. However, current treatments for prostate cancer patients in advanced stage often fail because of relapse. Prostate cancer stem cells (PCSCs) are resistant to most standard therapies, and are considered to be a major mechanism of cancer metastasis and recurrence. In this review, we summarized current understanding of PCSCs and their self-renewal signaling pathways with a specific focus on Wnt signaling. Although multiple Wnt inhibitors have been developed to target PCSCs, their application is still limited by inefficient delivery and toxicity in vivo. Recently, nanotechnology has opened a new avenue for cancer drug delivery, which significantly increases specificity and reduces toxicity. These nanotechnology-based drug delivery methods showed great potential in targeting PCSCs. Here, we summarized current advancement of nanotechnology-based therapeutic strategies for targeting PCSCs and highlighted the challenges and perspectives in designing future therapies to eliminate PCSCs.

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 68 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 18%
Student > Master 11 16%
Researcher 6 9%
Student > Bachelor 6 9%
Professor > Associate Professor 3 4%
Other 7 10%
Unknown 23 34%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 11 16%
Medicine and Dentistry 10 15%
Agricultural and Biological Sciences 7 10%
Chemistry 3 4%
Immunology and Microbiology 2 3%
Other 11 16%
Unknown 24 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 November 2021.
All research outputs
#6,505,767
of 23,316,003 outputs
Outputs from Frontiers in Pharmacology
#2,749
of 16,764 outputs
Outputs of similar age
#103,846
of 309,299 outputs
Outputs of similar age from Frontiers in Pharmacology
#40
of 201 outputs
Altmetric has tracked 23,316,003 research outputs across all sources so far. This one has received more attention than most of these and is in the 71st percentile.
So far Altmetric has tracked 16,764 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 309,299 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 201 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.